Full Text View
Tabular View
Study Results
Related Studies
The Montefiore Metoclopramide Study
This study has been completed.
Study NCT00475306   Information provided by Montefiore Medical Center

First Received on May 16, 2007.   Last Updated on November 28, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Nausea
Extrapyramidal Symptoms
Additional conditions recognized in this trial
Basal Ganglia Diseases
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
metoclopramide 10 mg
Diphenhydramine 25 mg
Placebo
Metoclopramide 20 mg
Additional drug interventions recognized in this trial
Diphenhydramine
Metoclopramide
Promethazine
More general drug interventions related to this trial
Anesthetics
Anesthetics, Local
Anti-Allergic Agents
Antiemetics
Antipruritics
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Dermatologic Agents
Dopamine Agents
Dopamine Antagonists
Gastrointestinal Agents
Histamine Agents
Histamine Antagonists
Histamine H1 Antagonists
Hypnotics and Sedatives
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Montefiore Medical Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services